- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- hetero-2-2-mer
- Ligands
- 4 x OXY: OXYGEN MOLECULE(Non-covalent)
- 4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
HEM.2: 20 residues within 4Å:- Chain A: Y.43, F.44, H.46, F.47, H.59, K.62, V.63, A.66, L.67, L.84, L.87, H.88, L.92, V.94, N.98, F.99, L.102, V.133, L.137
- Ligands: OXY.1
19 PLIP interactions:19 interactions with chain A,- Hydrophobic interactions: A:Y.43, A:Y.43, A:F.44, A:F.44, A:V.63, A:A.66, A:L.67, A:L.84, A:L.87, A:L.92, A:V.94, A:F.99, A:F.99, A:V.133, A:L.137
- Water bridges: A:H.59
- Salt bridges: A:H.46, A:K.62
- Metal complexes: A:H.88
HEM.5: 18 residues within 4Å:- Chain B: T.39, F.42, F.43, H.64, K.67, A.71, F.72, L.89, L.92, H.93, L.97, V.99, N.103, F.104, L.107, V.138, L.142
- Ligands: OXY.4
20 PLIP interactions:20 interactions with chain B,- Hydrophobic interactions: B:T.39, B:F.42, B:F.42, B:F.43, B:F.43, B:F.72, B:F.72, B:L.89, B:L.92, B:L.97, B:V.99, B:N.103, B:F.104, B:L.107, B:V.138, B:L.142
- Water bridges: B:S.45, B:H.64
- Salt bridges: B:H.64
- Metal complexes: B:H.93
HEM.7: 18 residues within 4Å:- Chain C: Y.43, F.44, F.47, H.59, K.62, V.63, A.66, L.84, L.87, H.88, L.92, V.94, N.98, F.99, L.102, V.133, L.137
- Ligands: OXY.6
18 PLIP interactions:18 interactions with chain C,- Hydrophobic interactions: C:Y.43, C:Y.43, C:Y.43, C:F.44, C:F.44, C:F.47, C:V.63, C:L.84, C:L.92, C:V.94, C:F.99, C:F.99, C:L.102, C:V.133, C:L.137
- Water bridges: C:H.59
- Salt bridges: C:K.62
- Metal complexes: C:H.88
HEM.10: 18 residues within 4Å:- Chain D: T.39, F.42, F.43, H.64, K.67, V.68, A.71, F.72, L.89, L.92, H.93, L.97, V.99, N.103, F.104, L.107, L.142
- Ligands: OXY.9
19 PLIP interactions:19 interactions with chain D,- Hydrophobic interactions: D:T.39, D:F.42, D:F.42, D:F.43, D:F.43, D:V.68, D:A.71, D:F.72, D:F.72, D:L.89, D:L.97, D:V.99, D:N.103, D:F.104, D:L.107, D:L.142
- Water bridges: D:S.45, D:S.45
- Metal complexes: D:H.93
- 2 x MW0: (5-methylfuran-2-yl)methanol(Covalent)
MW0.3: 8 residues within 4Å:- Chain A: V.2, L.3, K.128, A.131, S.132, T.135
- Chain C: T.135, S.139
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:V.2, A:A.131
- Hydrogen bonds: A:T.135
MW0.8: 7 residues within 4Å:- Chain A: T.135, S.139
- Chain C: V.2, L.3, A.131, S.132, T.135
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:V.2, C:L.3, C:A.131
- Hydrogen bonds: C:T.135, C:T.135
- Water bridges: C:T.135
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Alhashimi, R.T. et al., Design, Synthesis, and Antisickling Investigation of a Nitric Oxide-Releasing Prodrug of 5HMF for the Treatment of Sickle Cell Disease. Biomolecules (2022)
- Release Date
- 2022-03-30
- Peptides
- Hemoglobin subunit alpha: AC
Hemoglobin subunit beta: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CB
BD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- hetero-2-2-mer
- Ligands
- 4 x OXY: OXYGEN MOLECULE(Non-covalent)
- 4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 2 x MW0: (5-methylfuran-2-yl)methanol(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Alhashimi, R.T. et al., Design, Synthesis, and Antisickling Investigation of a Nitric Oxide-Releasing Prodrug of 5HMF for the Treatment of Sickle Cell Disease. Biomolecules (2022)
- Release Date
- 2022-03-30
- Peptides
- Hemoglobin subunit alpha: AC
Hemoglobin subunit beta: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CB
BD
D